nanostherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: | ||
Meta Tags
| Title | Nanoscope |
| Description | Nanoscope is focused on proprietary ambient light activated optogenetic therapy to restore vision in people suffering from all forms of Retinitis Pigmentosa, Stargardt and other inherited retinal degenerations as well as dry |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 50.62.195.83 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
nanostherapeutics.com Valuation
|
US$10,666,263
Last updated: 2022-06-28 07:00:34
nanostherapeutics.com has Semrush global rank of 992,316. nanostherapeutics.com has an estimated worth of US$ 10,666,263, based on its estimated Ads revenue. nanostherapeutics.com receives approximately 1,230,723 unique visitors each day. Its web server is located in United States, with IP address 50.62.195.83. According to SiteAdvisor, nanostherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$10,666,263 |
| Daily Ads Revenue | US$9,846 |
| Monthly Ads Revenue | US$295,374 |
| Yearly Ads Revenue | US$3,544,482 |
| Daily Unique Visitors | 82,049 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| nanostherapeutics.com. | A | 3600 | IP: 50.62.195.83 |
| nanostherapeutics.com. | NS | 3600 | NS Record: ns1.netfirms.com. |
| nanostherapeutics.com. | NS | 3600 | NS Record: ns2.netfirms.com. |
| nanostherapeutics.com. | MX | 1800 | MX Record: 0 nanostherapeutics-com.mail.protection.outlook.com. |
| nanostherapeutics.com. | MX | 3600 | MX Record: 10 mx.netfirms.com. |
| nanostherapeutics.com. | TXT | 1800 | TXT Record: DZC.nanostherapeutics.com |
| nanostherapeutics.com. | TXT | 1800 | TXT Record: MS=32A834028BB54C54B685D24934CD25337E11AD54 |
| nanostherapeutics.com. | TXT | 1800 | TXT Record: MS=ms42073175 |
| nanostherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 ip4:66.96.128.0/18 ?all |
| nanostherapeutics.com. | TXT | 1800 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-28 07:00:34
| Nanoscope Therapeutics Follow Us About Our Team Advisors Technology Pipeline News Press Releases In the News Upcoming Events Media Contact Contact Bringing Back the Light of Hope We are advancing gene therapies to restore sight to patients suffering from degenerative retinal disorders We intend to have the first treatment for Retinitis Pigmentosa Bringing Back the Light of Hope And change thousands of lives for the better News from Nanoscope Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration Patients “Presently all existing trials attempt to slow down the progression of vision loss in patients with Stargardt disease, Optogenetic approach is to restore vision. This can be a groundbreaking attempt to evaluate optogenetic gene therapy to improve vision in Stargardt patients. I’m excited by the potential MCO-010 has to restore vision for many patients with sight loss caused by outer retinal dystrophies including dry age-related |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 0 Content-Security-Policy: upgrade-insecure-requests Content-Type: text/html; charset=iso-8859-1 Date: Tue, 26 Oct 2021 05:30:22 GMT Location: https://nanostherapeutics.com/ Vary: User-Agent, Accept-Encoding X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect HTTP/2 200 server: openresty date: Tue, 26 Oct 2021 05:30:22 GMT content-type: text/html; charset=UTF-8 content-length: 134291 accept-ranges: bytes age: 37524 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
nanostherapeutics.com Whois Information
Domain Name: NANOSTHERAPEUTICS.COM Registry Domain ID: 2097882737_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2021-01-31T16:10:05Z Creation Date: 2017-02-15T17:20:08Z Registry Expiry Date: 2022-02-15T17:20:08Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.NETFIRMS.COM Name Server: NS2.NETFIRMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T06:34:22Z <<< |